Literature DB >> 19870370

THE NEUTRALIZATION TEST IN POLIOMYELITIS : COMPARATIVE RESULTS WITH FOUR STRAINS OF THE VIRUS.

J R Paul1, J D Trask.   

Abstract

In experiments devised to compare the neutralizing action of normal adult human sera on different strains of poliomyelitis virus, and to fill in certain gaps in our series of neutralization tests with different strains of virus on different types of cases in different age groups, we have made the following observations. 1. The difference between two human and two passage strains of the virus when tested by this method amounted to about 25 per cent, and there was less power in normal adult sera to neutralize human than passage strains of virus. 2. The differences between the two human strains amounted to 15 per cent, and between the two passage strains to 8 per cent, the last figure falling within the limits of the experimental error of the method. The extent to which these findings affect certain concepts with regard to the epidemiology of poliomyelitis based on passage strain neutralization experiments cannot be determined from the data presented in this paper, except that they more or less confirm the view previously derived from passage strain experiments, that 70 to 95 per cent of normal urban adults possess in their blood, substance which neutralizes poliomyelitis virus in a given amount. However, certain other indications appear when the present results are supplemented by those we have previously obtained (25). Primarily, we have found no relation between the clinical acquisition of poliomyelitis and the presence of substance in the serum which neutralizes a passage strain of poliomyelitis virus. With a passage strain the results seem rather to bear a closer relationship to age than to illness. With a human strain we have obtained results in which there is some evidence, shown only in the juvenile group, that acquisition of the clinical disease is accompanied by the appearance of antiviral properties in the blood.

Entities:  

Year:  1935        PMID: 19870370      PMCID: PMC2133235          DOI: 10.1084/jem.61.4.447

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  5 in total

1.  A COMPARATIVE STUDY OF RECENTLY ISOLATED HUMAN STRAINS AND A PASSAGE STRAIN OF POLIOMYELITIS VIRUS.

Authors:  J R Paul; J D Trask
Journal:  J Exp Med       Date:  1933-10-31       Impact factor: 14.307

2.  INTRADERMAL VERSUS SUBCUTANEOUS IMMUNIZATION OF MONKEYS AGAINST POLIOMYELITIS.

Authors:  F W Stewart; C P Rhoads
Journal:  J Exp Med       Date:  1929-05-31       Impact factor: 14.307

3.  THE DETECTION OF POLIOMYELITIS VIRUS IN SO CALLED ABORTIVE TYPES OF THE DISEASE.

Authors:  J R Paul; J D Trask
Journal:  J Exp Med       Date:  1932-08-31       Impact factor: 14.307

4.  A POTENT ANTIPOLIOMYELITIC HORSE SERUM CONCENTRATE AND ITS EXPERIMENTAL USE IN INFECTED MONKEYS.

Authors:  E R Weyer; W H Park; E J Banzhaf
Journal:  J Exp Med       Date:  1931-03-31       Impact factor: 14.307

5.  IMMUNITY TO POLIOMYELITIS IN MOTHERS AND THE NEWBORN AS SHOWN BY THE NEUTRALIZATION TEST.

Authors:  W L Aycock; S D Kramer
Journal:  J Exp Med       Date:  1930-09-30       Impact factor: 14.307

  5 in total
  5 in total

1.  A Review of Recent Studies on the Epidemiology of Poliomyelitis in the United States.

Authors:  J R Paul
Journal:  Yale J Biol Med       Date:  1938-07

2.  VIRUSES OF POLIOMYELITIS : AN IMMUNOLOGICAL COMPARISON OF SIX STRAINS.

Authors:  J D Trask; J R Paul; A R Beebe; W J German
Journal:  J Exp Med       Date:  1937-04-30       Impact factor: 14.307

3.  Cross-Reactive Antibody Responses against Nonpoliovirus Enteroviruses.

Authors:  Amy B Rosenfeld; Edmund Qian Long Shen; Michaela Melendez; Nischay Mishra; W Ian Lipkin; Vincent R Racaniello
Journal:  mBio       Date:  2022-01-18       Impact factor: 7.786

4.  Antibody response of patients with poliomyelitis to virus recovered from their own alimentary tract.

Authors:  A J STEIGMAN; A B SABIN
Journal:  J Exp Med       Date:  1949-10       Impact factor: 14.307

5.  THE INCIDENCE OF NEUTRALIZING ANTIBODIES FOR HUMAN INFLUENZA VIRUS IN THE SERUM OF HUMAN INDIVIDUALS OF DIFFERENT AGES.

Authors:  T Francis; T P Magill
Journal:  J Exp Med       Date:  1936-04-30       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.